Roche to Launch SARS-CoV-2 Rapid Antigen Test Nasal
The SARS-CoV-2 Rapid Antigen Test Nasal collects the sample from the front area of the nose instead of the nasopharynx, and can be self-collected.
Read MorePosted by Melanie Hamilton-Basich | Feb 11, 2021 | Covid 19, Rapid Assays |
The SARS-CoV-2 Rapid Antigen Test Nasal collects the sample from the front area of the nose instead of the nasopharynx, and can be self-collected.
Read MorePosted by Laurie Bonner | Feb 11, 2021 | Covid 19, Molecular Diagnostics |
Rush University Medical Center is opening an advanced molecular laboratory that will examine covid-19 samples from across Chicago to detect new strains of SARS-CoV-2.
Read MorePosted by Melanie Hamilton-Basich | Feb 10, 2021 | Company News, Covid 19, Rapid Assays |
The Carlsbad, Calif, Quidel facility aims to reach a run rate of 600 million QuickVue tests per year by the end of 2021.
Read MorePosted by Laurie Bonner | Feb 10, 2021 | Covid 19 |
Apple watches were able to measure subtle changes in participants’ heart rate variability and signal the onset of covid-19 up to 7 days before individuals were diagnosed via nasal swab.
Read MorePosted by Melanie Hamilton-Basich | Feb 10, 2021 | Covid 19, Flu & Respiratory Infections, Molecular Diagnostics |
Testing integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of covid-19 and its viral mutations, as well as Influenza A, B, and more.
Read More